VWR Expands Tissue-Diagnostics Offerings

VWR continues to expand in Europe and diversify by end-market, as this purchase focuses on clinical markets. The company reported in a recent SEC filing an aggregate purchase price, net of cash acquired, of $31.7 million as of June 30 for two acquisitions made this year (see IBO 2/15/14, 6/15/14).

Radnor, PA 9/10/14—VWR has acquired Netherlands- and Belgium-based Klinipath and its affiliates Immunologic, Mortupath and Klinipath BVBA for an undisclosed amount. Kilinipath provides equipment, consumables and reagents, representing suppliers for the histology, pathology, cytology, immunology and clinical chemistry industries, as well as supplies private-label equipment, reagents and plastic disposables. “Klinipath, Immunologic and Mortupath are recognized nationally throughout the Netherlands and Belgium as trusted brands,” commented Peter Schüle, VWR senior vice president and president, EMEA-APAC Lab and Distribution Services. “Klinipath supports VWR’s continued commitment to expand our capabilities and product portfolio, and extends our reach in the tissue-diagnostics industry.”

< | >